Chroma Medicine launches with $125M in financing

By The Science Advisory Board staff writers

November 17, 2021 -- Genomic medicine company Chroma Medicine has launched with $125 million in financing.

The funds will be used to advance programmable epigenetic editors that harness innate mechanisms to precisely control gene expression without changing or cutting the underlying DNA sequence, according to the company.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.